Form D · Other

Pharm, LLC

Scottsdale, AZ · CIK 0001679364

Offering snapshot reported Dec 27, 2018 · SEC filing

Reported sold
$7.1M
Offering amount: $75M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 14, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 27, 2018Initial$7,100,000No comparison3SEC filing
Mar 21, 2018Amendment$7,625,000$2,775,000vs Jul 10, 201724SEC filing
Jul 10, 2017Initial$4,850,000No comparison2SEC filing
Sep 6, 2016Initial$8,460,011No comparison23SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-329011
The Total Amount Sold excludes the conversion of an aggregate of $16.0 million 8% Convertible Subordinated Promissory Notes, plus accrued interest thereunder.

Source: Form D, filed Dec 27, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Wilfred Abbott Director
Will Abbott Director
William Abbott Director
Sjoerd Broeks Executive
Brent Cox Director
Barry Fischetto Executive
Yoram Heller Executive
Scott Minker Executive
Heather Molloy Director
Thomas Rini Director
Randy Smith Director, Executive
Chris Sung Executive
Michael Wang Executive

Issuer details

Industry: Other (See others in industry)

Address:
7201 E. Camelback Road Suite 350
Scottsdale, AZ, 85251